GENE ONLINE|News &
China Blocks Illumina’s Sequencers as U.S. Tariffs Double–Trade War Fallout Intensifies
BGI Genomics and MGI Tech, Illumina's competitors in China, experienced a surge in their stock prices after the company was prohibited from exporting its sequencers to the country.
China has banned imports of genetic sequencers from U.S. medical equipment maker Illumina (NASDAQ: ILMN), just minutes after U.S. President Donald Trump’s additional 10% tariff on Chinese goods took effect. The move is part of a broader set of actions China introduced in response to the new U.S. tariffs. This follows Beijing’s decision to add … China Blocks Illumina’s Sequencers as U.S. Tariffs Double–Trade War Fallout Intensifies Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Alliance for Clinical Trials in Oncology Highlights Research Initiatives on World Breast Cancer Research Day
2026-08-18
European Patent Office Grants Godavari Biorefineries Patent for Anti-Cancer Drug Formulation
2026-08-18
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
